Drugs / Autologous Dendritic Cell
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06193733 | Feb 2024 → Feb 2028 expected | hepatocellular carcinoma | Chang Gung Memorial Hospital | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT00323115 | May 2006 → Apr 2008 | glioblastoma | Dartmouth-Hitchcock Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Dendritic Cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00323115 ↗ |
| Modality | Cell therapy | “vaccination with autologous tumor lysate-loaded dendritic cells (DCs)” PMID 21499132 ↗ May 2011 |
| Route | Other | “Vaccine given by cervical lymph node injection 3 times every other week” NCT00323115 ↗ |